GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

14 hedge funds and large institutions have $4.93M invested in Amplify Treatments, Testing and Advancements ETF in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$254K
2
+$10.7K
3
+$66

Top Sellers

1
-$531K
2
-$412K
3
-$182K
4
Osaic Holdings
Osaic Holdings
Arizona
-$67.3K
5
Citadel Advisors
Citadel Advisors
Florida
-$39.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.63M
2
$668K
3
$321K
4
$203K
5
$34.2K
6
$29.2K
7
$10.7K
8
$7.82K
9
$7.69K
10
$5.99K
11
$4.52K
12
$3.91K
13
$3.13K
14
$88
15
–
16
–
17
–
18
–